Morgan Stanley takes 5.15% voting rights stake in Pentixapharm Holding
MS•Morgan Stanley builds stake in Pentixapharm
Morgan Stanley built a 5.15% voting rights stake in Pentixapharm, split between 3.15% in shares and 2% via an Equity Swap.
The threshold was reached on July 31, 2026.
The position represents 1,129,798 voting rights from shares, attributed indirectly, alongside 714,948 voting rights through the Equity Swap.
